Richard is a highly-respected investment writer well-known for his Share Sleuth portfolio, a model portfolio he runs for the investment platform Interactive investor. Richard eats his own cooking – buying good businesses at reasonable prices and holding them for the long-term in his Self Invested Personal Pension.
I’m a long-time ShareScope and SharePad fan and my aim is to help you find better companies faster using the fantastic tools at your disposal. My focus is on finding businesses we can reasonably expect to prosper for many years. As well as analysing data, I work out the strategies companies are following and try to verify that they are working in the real world by quizzing executives, visiting companies, trying their products and observing how they operate.
Digging deep into stock market sensation Halma’s history, Richard gains clues about the kind of businesses long-term investors should think about owning in an economic blizzard. I have never owned shares in Halma, in fact, I have never considered owning them even though the business has performed extraordinarily well. Halma: Proof that roll-ups can grow
Richard takes a first look at Dechra Pharmaceuticals, a company that has grown profit at a compound annual growth rate of 19% since 2013, yet its share price has halved this year. The financial year ending in June 2022, was Dechra Pharmaceuticals’ 25th anniversary. It was also the year the company joined the FTSE-100 index,
Richard takes a look at the segmental report of Cohort to gather insights into the company’s costs as it grows in complexity. The segmental report of another business shows how difficult it can be for companies to decide what they can and cannot tell us. I am a fan of some versions of the buy
Prompted by a SharePad user, Richard scares himself silly when he examines how sensitive the pension fund of one of his shareholdings is to changes in the rate of inflation. Other people notice things that we do not, which is one of the many reasons I value the emails from people who read my articles.
Richard writes an obituary for RM, his investment, rather than RM the business. It surprised him when it updated its risk report mid-term last week, despite what he had already learned. Perhaps it is because I do not scrutinise interim (half-year) results very often, or perhaps it is because I generally avoid heavily indebted companies,
A fellow investor is in a dilemma about one of her holdings: “Not sure what to do with the shares…” she writes. XP Power Ltd faces unanticipated challenges and the share price has more than halved. What should she do? An email from a reader has prompted me to think hard about XP Power. She
Finding good investment ideas among companies that have floated on the stockmarket recently can be like looking for a needle in a haystack. Richard thinks he knows what to look for, maybe it is Moonpig. Some of my favourite new investment ideas in recent months have been recent flotations, companies like Marks Electrical and Dr.
The fabric and wallpaper business is cheap and has a profitable past. Richard considers whether recovery will lead to sustainable growth… I am looking into Sanderson Design because an investor I know rates it and because as a former investor in Colefax, a customer and a competitor of Sanderson, I know (a little) about the
The world’s biggest bootmaker Dr Martens may be the strongest single brand company available to UK investors, but before he becomes invested for the second time in his life, there are a couple of objections Richard must overcome. Today, I am taking a first look at Dr. Martens, for three reasons: It has just published
Richard takes a first look at Learning Technologies, a company aggressively buying businesses that make employee training and development content and software. Learning Technologies’ is a slightly bewildering agglomeration of businesses that helps organisations get the best out of employees. It creates training content for employers and makes software both for the creation of training
Events at Luceco and Oxford Metrics may tell us more about the companies’ strategies, and whether they might make good long-term investments. Richard investigates. It is hard to believe Luceco’s share price is below the price it floated at in 2016, when turnover was 71% higher in the year to December 2021 than it was
Shortly after Judges Scientific makes its biggest-ever acquisition, Richard sets out to discover whether the pasture is greener over at SDI, a smaller listed business that does much the same thing: buys and builds companies that make scientific instruments. If I were to use one measure to compare highly acquisitive businesses it would be Return